Inhibition  of  Kupffer  cell  functions  modulates  arsenic  intoxication  in  Wistar  rats by Adeyemi, O. S. et al.
219
Inhibition of Kupffer cell functions modulates arsenic intoxication 
in Wistar rats
Oluyomi S. Adeyemi1, Ekong Meyakno1 and Musbau A. Akanji2 
1 Medicinal Biochemistry and Toxicology Laboratory, Department of Biological Sciences, Landmark University, Omu-Aran, 
Nigeria
2 Department of Biochemistry, University of Ilorin, Nigeria
Abstract. Study determined the influence of the inhibition of Kupffer cell functions by GdCl3 in ar-
senic intoxication. Twenty-four Wistar rats weighing between 150 and 160 g were randomly assigned 
into four groups. Group 1 received sodium arsenite (1.5 mg/kg b.w.) once a day, Group 2 received 
GdCl3 (2 mg/kg b.w.) once, 24 hours before commencing the arsenite (1.5 mg/kg b.w.) treatment. 
Group 3 received GdCl3 (2 mg/kg b.w.) once and subsequently given distilled water. Group 4 received 
distilled water only. The treatments were daily by oral gavage and lasted for 28 days. Animals were 
euthanized 24 hours after the last treatment. Arsenic exposure elevated the activities of rat plasma 
AST, ALT, ALP and γ-GT, indicative of liver injury. Arsenic exposure in rat lowered GSH concentra-
tion but potentiated inflammation and oxidative stress evidenced in the raised levels of MPO, NO 
and MDA. Rats with arsenic exposure were predisposed to atherosclerosis, lowering the HDL-C but 
elevated the LDL-C concentration. The histopathological assessment showed degenerating cellular 
lesion caused by arsenic. However, the inhibition of Kupffer cell functions by GdCl3 suppressed arsenic 
intoxication improving the liver function indices, oxidative stress status, lipid profile, neutrophilic 
inflammation and ultimately restored the cellular architecture. Data suggest that specific inhibition 
of Kupffer cells by GdCl3 protected against arsenic intoxication. 
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Introduction
Arsenic, as trivalent (As3+) and pentavalent salt (As5+), is 
released into the environment via agricultural, industrial and 
medical applications (Aliyu et al. 2012). Arsenic is a toxic 
metalloid and a common contaminant of drinking water. 
Arsenical exposure through drinking water is common and 
occurs in many areas of the world (Morakinyo et al. 2010). 
Consumption of arsenic-contaminated water increases risk 
of cardiovascular disease, lung disease, hepatic disease, 
and cancer in millions of people worldwide (Okoji et al. 
2002; Straub et al. 2008; Das et al. 2012; Kumar et al. 2014). 
Arsenic-contaminated drinking water is associated with sev-
eral adverse health effects in many developing areas around 
the world, including China, India, Mexico, and Bangladesh 
(Aliyu et al., 2012; Das et al. 2012).
Arsenite intoxication limits ATP production (Hughes et 
al. 2011), while potentiating oxidative stress which readily 
leads to cellular dysfunction (Rana et al. 2011). While the 
mechanism of arsenic toxicity remains limited, current 
treatment and preventive measures for arsenic intoxica-
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tion are still elusive (Chowdhury et al. 2006). Therefore, 
identifying the cellular factors that contribute to modulate 
the liver response to arsenicals is central to understanding 
their toxicology. We reasoned that, identifying cellular fac-
tors involved in liver response to arsenic intoxication would 
further aid our understanding of its mode of toxic action as 
well as provide opportunity for the development of newer 
treatment strategy. 
Kupffer cells are macrophage native to the liver and 
mediate hepatic response to chemical assault (Roberts et al. 
2007). Generally, Kupffer cells play an important role in the 
normal physiology and homeostasis of the liver as well as 
participate in the acute and chronic responses of the liver to 
toxic compounds and have been shown to modulate hepatic 
injury (Yee et al. 2000; Roberts et al. 2007). Several studies 
have demonstrated the central role played by Kupffer cells 
in liver responses to the toxic action of several drugs (Yee et 
al. 2000; Ju et al. 2002; Ito et al. 2003; Prins et al. 2004; Yao 
et al. 2004; Kresse et al. 2005). Meanwhile, it has been dem-
onstrated that pretreatment of mice with GdCl3, a specific 
inhibitor of Kupffer cells, offered protection against liver 
injury (Jorgensen et al. 2001). Further, in a separate inves-
tigation, Ding et al. (2003) showed that the intraperitoneal 
administration of GdCl3 to mice at doses between 10–20 
mg/kg caused apoptosis of Kupffer cells and blocked the 
Kupffer cell effector function without necessarily damag-
ing the liver. Currently, there is no empirical data on how 
Kupffer cells affect arsenic toxicity. Therefore, determining 
the role Kupffer cells play in arsenical intoxication may be 
essential to understanding the mode of the toxic action. To 
this end, this study evaluated the influence of the inhibition 




All chemicals and reagents used were of analytical grade. 
Sodium arsenite (NaAsO2) and GdCl3 were products of 
Sigma Chemicals (St. Louis, MO, USA). Reagent assay kits 
for aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), γ-glutamyl transferase (γ-GT), total cholesterol 
(CHOL), high-density lipoprotein (HDL), bilirubin, and 
albumin were products of Randox Laboratories (Crumlin, 
UK). 
Experimental animals
Twenty-four male Wistar rats weighing between 150 and 
160 g were purchased from the experimental animal farm 
at the Landmark University, Nigeria. The rats were housed 
in plastic cages and kept in a  well-ventilated room, with 
alternate light and dark cycle (12 h each). The animals were 
acclimatized for 14 days before the treatment commenced. 
The animals were fed standard rat chow and clean water 
ad libitum. Handling of animals was in accordance with 
relevant institutional and ethical guidelines as approved for 
scientific study.
Experimental design
The Wistar rats were randomly assigned into four groups. 
Details of groupings and treatments are as follows:
Group 1: Administered with arsenite (NaAsO2) at 1.5 mg/
kg body weight.
Group 2: Administered once with GdCl3 at 2 mg/kg b.w., 
24  h  before starting treatment with arsenite (NaAsO2) at 
1.5 mg/kg b.w.
Group 3: Administered once with GdCl3 at 2 mg/kg b.w. and 
subsequently received distilled water. 
Group 4: Administered with distilled water and served as 
sham control.
The arsenite dose was premised on report by Zaki et al 
(2011). The arsenite dose 1.5 mg/kg body weight/day falls 
within the range of LD50 of a 70 kg b.w. human (1–4 mg/
kg) and lesser than 1/25 of LD50 of rats (40 mg/kg). The 
treatments were daily by oral gavage and lasted for 28 days. 
Handling of animals was as approved by the Landmark 
University Research Ethics Committee and consistent with 
relevant guidelines on the care and use of laboratory animals 
(National Research Council 2011).
Necroscopy
Rats were sacrificed under mild chloroform anesthesia 
24 h after the last treatments. Blood samples were collected 
into EDTA bottles, centrifuged at 5000 × g  for 5 minutes 
in a  refrigerated centrifuge (Anke TDL-5000B, Shanghai, 
China) to obtain the plasma used for the biochemical deter-
minations. The liver from each animal was excised into iced 
isotonic solution (pH 7.4) and weighed immediately. A fifth 
of the liver sample was homogenized in iced 0.25 M sucrose 
solution (1:5, w/v). The liver homogenates were used for the 
biochemical determinations. The remaining part of the liver 
was fixed in 10% buffered neutral formalin (BNF) and used 
for histopathology examinations. 
Biochemical assays
The biochemical parameters were determined in rat plasma 
using a UV/Vis spectrophotometer (Jenway, Staffordshire, 
United Kingdom) where applicable. The concentration of 
rat plasma total protein (TP), aspartate aminotransferase 
(AST, EC: 2.6.1.1), alanine aminotransferase (ALT, EC 
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2.6.1.2), alkaline phosphatase (ALP, EC: 3.1.3.1), γ-glutamyl 
transferase (γ-GT, EC 2.3.2.2), bilirubin, albumin, lipid 
profile including total cholesterol (CHOL), high-density 
lipoprotein-cholesterol (HDL-C) were determined using 
Randox assay kits (Crumlin, UK). The low-density lipo-
protein cholesterol (LDL-C) was estimated according to 
the Friedewald formula (Warnick et al. 1990). Total protein 
was determined using the Lowry’s method (Lowry et al. 
1951). Reduced glutathione level (GSH) was determined 
by the procedure described by Ellman (1959) and Akanji et 
al (2009). Malondialdehyde (MDA) was determined using 
the method described by Niehaus and Samuelson (1968). 
The concentration of nitric oxide as nitrite/nitrate level was 
determined using the Greiss method according to method 
described by Ekanem et al. (2009). The myeloperoxidase 
(MPO – EC 1.11.2.2) activity was determined as previously 
described (Adeyemi and Sulaiman 2014), according to the 
method by Eiserich et al. (1998).
Histopathological examination
The rat liver was fixed in 10% buffered neutral formalin 
immediately following excision from animals. Fixed tissues 
were subsequently processed for histopathological examina-
tions as previously described (Adeyemi and Sulaiman 2012). 
Capture and scoring for morphological changes were done 
by a pathologist blind to the treatments, at the University of 
Ilorin Teaching Hospital, Ilorin, Nigeria. The photomicro-
graphs were captured at ×100 using the software “Presto! 
Image Folio package”.
Data analysis 
Data were analyzed using the one-way ANOVA (GraphPad 
Software Inc., San Diego, CA) and presented as the mean ± 
standard error of mean (SEM). Differences among the group 
means were determined by the Tukey’s test. Mean values at 
p < 0.05 were considered to be significant. 
Results
Arsenite exposure had no appreciable effect on rat aver-
age weights when compared to the other treatment groups 
(Fig. 1). However, the rat liver weights as well as the liver-
to-body weight ratio were significantly reduced by arsenite.
Furthermore, oral exposure of rats to arsenite did not 
alter the concentration of plasma total protein. In contrast, 
the rat plasma albumin concentration was appreciably 
decreased relative to the other treatment groups (Fig. 2). 
Arsenic treatment in rats led to a significant elevation of 
plasma bilirubin concentration relative to the other treat-
ments.
Figure 1. Effect of oral exposure of rats to arsenite and/or gadolini-
um chloride (GdCl3) on average rat weight (A), rat liver weight (B) 
and liver-to-body weight ratio  (C). Data are presented as mean 
value ± standard error of mean (SEM), n = 6. α is significant at p < 
0.001 relative to arsenic only.
In comparison to the other treatment groups, the oral 
exposure of rats to arsenic for 28 days suggest impairment to 
liver function as evidenced by increased (p < 0.05) activities 
of plasma AST, ALT, ALP and γ-GT (Fig. 3). Also, arsenic 
exposure elevated rat plasma and hepatic MDA concentra-
tion but depleted the GSH levels when compared to the other 
treatments (Fig. 4). Likewise, arsenic exposure increased the 
levels of MPO and NO relative to the other treatment groups 
(Fig. 5). The rat plasma lipid profile was not spared, as arsenic 
exposure elevated the concentration of CHOL, LDL-C but 
reduced the HDL-C level, thereby increasing the atherogenic 
index (AI). The negative alterations of plasma lipid profile by 
arsenic were absent in the other treatment groups (Fig. 6).
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The histopathological assessment of rat liver sections 
showed inimical cellular lesions including congestion and 
inflammation caused by arsenic exposure (Fig. 7). However, 
pre-treating rats with GdCl3 before daily exposure to arsenic 
improved the cellular alterations. In the other groups that 
received GdCl3 alone and/or distilled water only, the liver 
cellular architecture was intact.
Discussion 
Arsenic is a toxic metalloid (Aliyu et al. 2012; Das et al. 2012). 
However, the knowledge of the mechanism of arsenic toxicity 
Figure 2. Effect of oral exposure of rats to arsenite and/or gado-
linium chloride (GdCl3) on rat plasma protein concentration (A), 
rat plasma albumin  (B) and rat plasma bilirubin  (C). Data are 
presented as mean value ± SEM, n = 6. α is significant at p < 0.001 
relative to arsenic only.
Figure 3. Effect of oral exposure of rats to arsenite and/or gadolinium 
chloride (GdCl3) on rat plasma aspartate transaminase (AST) activ-
ity (A), rat plasma alanine transaminase (ALT) activity (B), rat plasma 
alkaline phosphatase (ALP) activity (C) and rat plasma γ-glutamyl 
transferase (γ-GT) activity (D). Data are presented as mean value 
± SEM, n = 6. α is significant at p < 0.001 relative to arsenic only.
remains limited. We reasoned that, identifying the cellular 
factors that contribute to modulate the response to arseni-
cal toxicity would provide for a better understanding of the 
mode of toxicity. Kupffer cells have been shown to modulate 
hepatic injury as well as play key role in the mediation of 
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using aimed to determine how Kupffer cells affect arsenic 
intoxication by using GdCl3 to inhibit Kupffer cell functions. 
Arsenic exposure in rats significantly reduced the rat liver 
weight as well as the liver-to-body weight ratio. This may 
indicate ensuing adverse effect by arsenite as studies have 
associated changes to body or organ weights with chemical 
or drug intoxication (Adeyemi and Orekoya 2014; Sulaiman 
et al. 2015). This is consistent with other studies have demon-
strated arsenic-induced changes to rat body or organ weights 
(Aliyu et al. 2012; Chandraayagam et al. 2013).
Further evidence for arsenite-induced liver injury is re-
flected by the negative alteration of the activities of rat plasma 
AST, ALT, ALP and γ-GT. Increased liver function indices 
are evidence of liver damage (Adeyemi and Akanji 2011a; 
Adeyemi et al. 2012). The arsenic-induced elevation of liver 
function indices is consistent with the potential to cause liver 
damage (Gbadegesin and Odunola 2010; Das et al. 2012; 
Kumar et al. 2014). More so, the arsenite-induced negative 
alteration of the plasma albumin and bilirubin concentra-
tion suggests liver injury or reduced functioning capacity.
The arsenic exposure also caused oxidative stress by 
potentiating lipid peroxidation while depleting the GSH 
concentrations. GSH plays key role protecting against metal 
toxicity (Swaran et al. 2005; Mishra et al. 2008) and its deple-
Figure 4. Effect of oral exposure of rats to arsenite and/or gado-
linium chloride (GdCl3) on rat plasma malondialdehyde (MDA) 
concentration (A), rat hepatic malondialdehyde (MDA) concentra-
tion (B), rat plasma reduced glutathione (GSH) concentration (C) 
and rat hepatic reduced glutathione (GSH) concentration (D). Data 
are presented as mean value ± SEM, n = 6. α is significant at p < 
0.001 relative to arsenic only. 
Figure 5. Effect of oral exposure of rats to arsenite and/or gadolini-
um chloride (GdCl3) on rat plasma nitric oxide (NO) concentration 
measured as nitrate/nitrite level (A) and rat plasma myeloperoxi-
dase (MPO) activity (B). Data are presented as mean value ± SEM, 
n = 6. α is significant at p < 0.001 relative to arsenic only. 
metal toxicity (Roberts et al. 2007). Therefore, identifying 
the role Kupffer cells play in arsenic intoxication would aid 
understanding the mode of toxicity. The present study by 
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Several studies have implicated arsenic for lipid peroxida-
tion, oxidative stress as well as liver damage (Zaki et al. 2011; 
Chandranayagam et al. 2013). Arsenic’s reactivity toward 
sulfhydryl groups may affect several cellular functions. 
Studies have demonstrated that arsenite has affinity for thiol 
groups and could cause damage by promoting generation 
of reactive species (Shiobara et al. 2001; Rana et al. 2011). 
The increased level of MPO and NO, consequent of ar-
senite intoxication may also have aided the lipid peroxida-
tion as well as resultant oxidative cellular damage. Elevated 
production of NO can react with metals, reduced thiols, mo-
lecular oxygen and superoxide leading to adverse reactions 
(Bryan et al. 2005; Gladwin et al. 2005) leading to cellular 
damage (Adeyemi and Sulaiman 2014). Likewise, increased 
activity of MPO has been linked to oxidative cellular dam-
age (Adeyemi and Akanji 2011b). MPO plays vital role in 
neutrophilic inflammation (Vita et al. 2004), and has been 
shown to potentiate atherosclerosis (Hazen et al. 2004). In 
like manner, the present study showed that arsenite exposure 
has capacity to predispose rats to cardiovascular disorder by 
increasing plasma total CHOL, LDL-C, while lowering the 
HDL-C levels which raised the atherogenic index. Elevated 
atherogenic index has been associated with the develop-
ment of atherosclerosis (Olukanni et al. 2013; Adeyemi and 
Orekoya 2014). Our findings agree with studies that have 
linked arsenic toxicity to cardiovascular disorders (Straub 
et al. 2008; Das et al. 2012; Kumar et al. 2014).
Furthermore, the histopathological assessment of rat liver 
sections showed cellular lesion caused by arsenite exposure. 
This supports the biochemical evaluations. Arsenic intoxi-
cation has been shown to cause hepatic fibrosis and other 
degenerating cellular lesions (Datta et al. 2007; Rana et al. 
2011; Zaki et al. 2011; Abnosi and Jafaru 2012) similar to the 
observation in the present study. 
However, the pre-treatment of rats with GdCl3 to inhibit 
the Kupffer cell functions before arsenite exposure sup-
pressed and protected against arsenite intoxication by im-
proving the liver function indices, the oxidative status, lipid 
profile and ultimately the cellular architecture. The Kupffer 
cells play central role in the hepatic response to toxicants or 
carcinogens. The activation of Kupffer cells either directly or 
indirectly promotes the release of inflammatory mediators as 
well as reactive oxygen species (ROS) which help modulate 
hepatic injury. In this study, the inhibition of Kupffer cell 
functions by GdCl3 may have reduced the production of 
inflammatory mediators including NO and MPO thereby 
protecting against cellular inflammation and damage. NO 
and MPO under certain conditions are pro-inflammatory 
and the duo have been implicated for cellular damage (Adey-
emi and Sulaiman 2014). This suggests that Kupffer cells 
are a target for arsenic toxicity. The arsenic exposure may 
have activated the Kupffer cells for protective response that 
develops to cause cellular damage with further stimulation. 
Figure 6. Effect of oral exposure of rats to arsenite and/or gado-
linium chloride (GdCl3) on rat plasma total cholesterol concentra-
tion (A), rat plasma high density lipoprotein-cholesterol (HDL-C) 
concentration (B), rat plasma low density lipoprotein-cholesterol 
(LDL-C) concentration (C), and rat atherogenic index (AI – LDL/
HDL ratio) (D). Data are presented as mean value ± SEM, n = 6. 
α is significant at p < 0.001 relative to arsenic only.
tion may signal oxidative stress (Akanji et al. 2009). In the 
present study, the use of GSH to detoxify arsenite may have 
led to the depletion and ensuing oxidative stress observed. 
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This is plausible considering that the inhibition of Kupffer 
cell functions by GdCl3 significantly reduced and improved 
the indices of arsenite intoxication. Findings in the present 
study revealed consistence with Roberts et al (2007) which 
reported that GdCl3 inhibition of Kupffer cells could mitigate 
chemical intoxication as well as resultant cellular damage.
Conclusion
Although Kupffer cells have dual role in the hepatic response 
to chemical toxicity, our data supports the complicity of 
Kupffer cells in arsenite intoxication. To our knowledge, this 
is the first study showing evidence that inhibiting Kupffer 
cell functions by using GdCl3 offered protection against 
arsenite intoxication in rats. Data would contribute to our 
understanding of the mechanism of arsenite intoxication. 
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